InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: fred198484 post# 16773

Monday, 08/21/2017 5:37:17 PM

Monday, August 21, 2017 5:37:17 PM

Post# of 233150
Only disagreeing with your last point - no need to close the trial (in fact, they haven't to our knowledge) in order to disclose results from the 24-week extension arm since that one is open label. They're free to share information on that, when and if they so choose. The one-week efficacy primary endpoint is the only thing they need to close the trial and unblind the data for, to my knowledge. They weren't "forced" to do anything in that regard.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News